Cresco Labs Inc. (CRLBF) stock
CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 6, 2026Score 4/30
$0.58−0.02 (-3.13%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Cresco Labs ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was $20.73M, down 87.5% from the year before. The highest annual figure on record is $166.39M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.73M | -87.5% |
| FY2024 | Dec 31, 2024 | $166.39M | – |
| FY2023 | Dec 31, 2023 | -$25.31M | – |
| FY2022 | Dec 31, 2022 | -$32.37M | – |
| FY2021 | Dec 31, 2021 | -$178.71M | -2246.4% |
| FY2020 | Dec 31, 2020 | $8.33M | – |
| FY2019 | Dec 31, 2019 | -$22.35M | – |
See a number that looks wrong?